Risks of novel oral prostate cancer therapies and pre-existing conditions
A new large population-based study shows that novel oral androgen signalling inhibitor therapies are associated…
Browsing: oral androgen signalling inhibitor therapies
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Modern anti-cancer drugs work via tiny molecular motions
- Study examines role of biomarkers to evaluate kidney injury in cancer patients
- How genes and environment conspire in pancreatic cancer development discovered
- Researchers discover mechanism to overcome drug-resistance in leukaemia
- The OJC Episode 22: Disparity Special
- Does aspirin lower colorectal cancer risk in older adults? It depends on when they start
- Pre-surgery chemotherapy is possible for early stage pancreatic cancer patients
- Better post-surgery care would dramatically improve cancer survival in LMICs
